Salicylamide derivatives as nicotinic alpha 7 modulators

Details for Australian Patent Application No. 2009281243 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Elworthy, Todd Richard

Agent Spruson & Ferguson

Pub. Number AU-A-2009281243

PCT Pub. Number WO2010/018095

Priority 61/088,108 12.08.08 US

Filing date 3 August 2009

Wipo publication date 18 February 2010

International Classifications

C07C 235/60 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07C 235/62 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2010/018095 Priority application(s): WO2010/018095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281244-Substrate-free decorative surface covering

2009281242-Surface covering with static control properties